AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial. - Medina S; Tokuyama N; Putcha V; Pathak T; Fu P; Thomas H; Subhash VV; Yip S; Lin HM; Horvath LG; Kench JG; Zhang A; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)